Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 485	$ 822
Trade receivables, net of credit losses	3,047	2,993
Retention credit receivable		10
Other receivables	288
Notes receivable from related parties	5,571	5,501
Prepaid expenses and other current assets	279	442
Total current assets	9,670	9,768
Other intangible assets, net	3	3
Property, plant and equipment, net	13	15
Total assets	9,686	9,786
CURRENT LIABILITIES
Factoring liability	149	174
Accounts payable	592	548
Accrued expenses	285	290
Accrued payroll	644	637
Deferred revenue	217	206
Total current liabilities	1,887	1,855
Total liabilities	1,887	1,855
Commitment and contingencies (Note 6)
Subsequent events (Note 10)
SHAREHOLDERS’ EQUITY
Common stock, without par value, 300,000,000 shares authorized, 300,000,000 issued and outstanding as of March 31, 2024 and as of December 31, 2023
Additional paid-in capital	750	750
Retained earnings	7,049	7,181
Total shareholders’ equity	7,799	7,931
Total liabilities and shareholders’ equity	$ 9,686	$ 9,786